Clarivate

APRIL 18, 2024

While the key players’ strategies differ, all are focused on bending the cost curve while increasing patient touchpoints and engagement. More recent developments provide a look into Amazon’s interest in treating patients with chronic conditions, including a pharmacy consultation pilot for high-risk seniors with complex medical needs.

Retail 52

Retail Healthcare Healthcare Physicians 52

pharmaphorum

JANUARY 9, 2023

Albireo secured approval in the US and Europe for the ileal bile acid transport inhibitor (IBATi) drug in 2021 for the treatment of pruritus (itching) in patients with rare disorder progressive familial intrahepatic cholestasis (PFIC), and has said sales should reach $24 million this year.

Transportation 52

Transportation Sales Leads FDA 52

PM360

JULY 13, 2023

1 This increased technology spending has led to industry fragmentation, creating siloed data—which can leave providers with an incomplete picture of a patient’s health record—and an often-cumbersome experience for patients, leaving them to shoulder the burden of managing their own care. billion in 2020 and is expected to reach $381.7

Healthcare 98

Healthcare Healthcare Consulting Healthcare Provider 98

PM360

OCTOBER 24, 2022

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing, and delivering innovative human therapeutics. Amgen also offers a training curriculum to prepare new managers to lead and inspire their teams. Within the U.S., Social Responsibility.

Pharma 40

Pharma Medicine Education Manufacturing 40

Pharmaceutical Technology

DECEMBER 16, 2022

GnRH antagonists have an improved safety and efficacy profile compared to the marketed GnRH agonists, which have significant side effects that are unappealing to patients. This therapy is currently in Phase II development and is expected to launch in the US and 5EU in 2027 and 2028, respectively.

Marketing 59

Marketing Side effects Sales Safety 59

Medico Reach

SEPTEMBER 12, 2022

Upon immediately subjecting the patient to an X-ray, the barium appears white as doctors observe how it outlines the digestive tract. . Option to treat the patient during endoscopy. But since the patient is already sedated while performing the procedure, the doctor can treat the problem during endoscopy. billion by 2027.

Marketing 52

Marketing Doctors Training Medical 52

PM360

SEPTEMBER 21, 2023

As a mission-driven company and digital healthcare leader, GoodRx has helped patients obtain an estimated 80 million prescriptions they otherwise may not have been able to afford. 1 We have been improving patient affordability for over a decade, across generic and brand medications, including specialty treatments—sometimes by more than 50%.

Prescription 52

Prescription Medical Patients Distribution 52

PM360

DECEMBER 14, 2022

In its latest venture into the healthcare arena, Amazon is reaching out directly to the consumer via its soon-to-be-launched Amazon Clinic , a virtual health service for patients to see licensed clinicians about common medical issues. billion euros into its new facility where it is planning to hire 400 and 500 new personal by 2027.

Manufacturing 52

Manufacturing Medical Healthcare Healthcare 52

Medico Reach

DECEMBER 2, 2022

billion , and by 2027, it is expected to reach around an exciting amount of 115.1 from 2022 to 2027. Some clinical trials offered by PPD include: Early Development Consulting and Product Development PPD Biotech PPD FSP The site and patient-centered Solutions Clinical Development. billion with a CAGR of 11.0% Medpace Holdings.

Consulting 98

Consulting Specialization Medicine Medical 98

European Pharmaceutical Review

MARCH 7, 2024

Last month, construction began on Europe’s first industrial-scale facility dedicated to the production of lead-212 based radioligand therapies. billion between 2022 to 2027. percent for the gastroenteropancreatic neuroendocrine tumours (GEP-NET) patients who had never received radioligand therapy).

Manufacturing 52

Manufacturing Food and Drug Administration Marketing Management 52

PM360

APRIL 7, 2023

However, Medicare will only be able to negotiate prices for 10 Part D drugs in 2026, another 15 Part D drugs in 2027, another 15 Part D and Part B drugs in 2028, and another 20 Part D and Part B drugs for 2029 and subsequent years. Impact Beyond Medicare The IRA won’t just impact negotiation with the government either.

Marketing 52

Marketing Pharma Manufacturing Healthcare 52

Medico Reach

SEPTEMBER 19, 2022

Remote monitoring and analysis of a patient’s health lower costs associated with the following aspects: Service costs Patient visit expenses Data storage costs Auxiliary insurance costs. Improved Patient Engagement. A satisfied patient is a vital asset for any healthcare provider. Enhanced Patient Outcomes.

Healthcare 52

Healthcare Healthcare Healthcare Provider Physicians 52

European Pharmaceutical Review

MARCH 4, 2024

percent through 2027. Therefore, biologics identification and characterisation poses unparalleled challenges, as does their manufacturing processes and routes of administration while maintaining patient safety and clinical efficacy. Standardising isolation, purification and storage processes are crucial areas for further improvement.

Food and Drug Administration 88

Food and Drug Administration Transportation FDA Medical 88

Medico Reach

FEBRUARY 8, 2023

AI can lead to faster research, combining and extracting data into usable formats, making clinical trials more efficient and saving time. Big data can help clinical trial design, allowing researchers to leverage genetic makeup, historical patient data, past trial results, demographics, and more to find the right participants.

Pharma 52

Pharma Medicine Marketing Prospecting 52

Clarivate

OCTOBER 25, 2023

The dearth of cancer drugs (only blood cancer drug Imbruvica made this first list) stems from CMS only pursuing negotiations for Part D drugs in 2026 and 2027, then expanding to Part B drugs in 2028. The biggest impacts are likely to be felt by patients with PDPs that use coinsurance, which most plans do for specialty drugs.

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

Pharmaceutical Technology

JANUARY 10, 2023

Many of the current existing therapies are often viewed by physicians as not optimal to addressing the needs of patients, and challenges remain such as improving patient compliance, safety profile, and addressing comorbidities of T2D. billion in 2029, although its sales growth is likely to continue beyond 2029.

Marketing 52

Marketing Physicians Leads Sales 52

Clarivate

APRIL 24, 2023

Health systems will buy or establish an insurance plan to serve as an extension of their continuum of care, a means of directing referral streams to increase revenue and securing control over clinical and formulary decisions for patients.

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

PM360

JUNE 29, 2022

But to succeed, players must deeply understand both the end-to-end consumer and patient experience and create an ecosystem of partners to deliver the care, products, and experiences that health-conscious consumers need. Prescription refills can now be placed with a simple click on a patient portal. Reconsider the Role of Packaging.

Retail 97

Retail Healthcare Healthcare Marketing 97

Star OUTiCO

FEBRUARY 18, 2022

For pharma and the NHS, this manifested itself in unprecedented changes to the way the latter delivers patient care, while the former – historically a little conservative on the digital uptake – became a beacon of inspiration for what’s possible when there is a strong sense of urgency. The ultimate benefactor, of course, is the patient.”

Pharma 52

Pharma Healthcare Healthcare Patients 52

Evolve Your Success

OCTOBER 31, 2023

Neuromodulation isn’t just about stimulating nerves; it’s about awakening hope and transforming lives—one patient at a time. In this episode, Blake Williams takes us on a wild journey through his career as a Field Clinical Engineer (FCE), shedding light on the incredible impact of neuromodulation on the lives of patients.

Engineering 52

Engineering Sales Medical sales Physicians 52

pharmaphorum

JANUARY 16, 2023

Even where there has been innovation, for example in cholesterol lowering with PCSK-9s and the siRNA treatment Leqvio, the vast majority of patients are on generic versions of medicines launched in the 1990s, and innovative medicines have not transformed the treatment paradigm. Innovation will power the market.

FDA 84

FDA Healthcare Healthcare Medicine 84

European Pharmaceutical Review

OCTOBER 12, 2023

With the goal of supplying cell therapies, vaccines and other essential medicines such as antibody drugs to patients, the facilities aim to address major supply challenges and navigate the intricacies of producing fragile biological products. Meath opened last month.

Pharmaceutical manufacturing 84

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharma 84

pharmaphorum

SEPTEMBER 22, 2022

The “US-first” mindset will lead to higher proportions of American patients in its clinical trials and investment in “capability and talent” in the US, where it aims to become a top-five player by 2027 – a big advance on its current 10th place. billion by 2024.

Management 52

Management Sales Patients Medicine 52

pharmaphorum

OCTOBER 6, 2022

Earlier this year, Novo Nordisk said that once-weekly injection Wegovy was emerging from a challenging early rollout beset by production problems, and is now expected to lead an obesity franchise at the company that could reap $3.7 In SURMOUNT-1, patients taking a weekly injection of the drug saw an average 22.5% billion in 2025 sales.

Sales 52

Sales Marketing FDA Leads 52

European Pharmaceutical Review

FEBRUARY 22, 2023

1 Used to treat a range of chronic diseases (eg, diabetes, rheumatoid arthritis, psoriasis, Crohn’s disease, haemophilia, etc), it is projected that the sales of biologics will rise from $380 billion in 2022 to $416 billion in 2023, and to almost $600 billion in 2027. the enteric coating and the capsule dissolve. Diabetes Therapy.

Food and Drug Administration 88

Food and Drug Administration Manufacturing Safety Pharmaceutical 88

Pharmaceutical Technology

APRIL 24, 2023

The rise of biologics In the lead-up to the 2020 boom, Swiss drugmaker Roche spent some $11 billion on biotechnology research and development in 2018. Syngene, which is among the leading CRDMOs in India, has biologics facilities that can produce a large array of products across mammalian and microbial platforms.

Manufacturing 52

Manufacturing Food and Drug Administration Biopharma Sales 52

Pharmaceutical Technology

NOVEMBER 30, 2022

Previously, the standard of care for obesity consisted of holistic changes to diet, exercise, and bariatric surgery for eligible patients. However, despite the effectiveness of bariatric surgery, many obese patients are reluctant to undergo surgical procedures, opening the opportunity for a pharmaceutical approach.

Medical 105

Medical Manufacturing Insurance Side effects 105

Pharmaceutical Technology

NOVEMBER 30, 2022

Previously, the standard of care for obesity consisted of holistic changes to diet, exercise, and bariatric surgery for eligible patients. However, despite the effectiveness of bariatric surgery, many obese patients are reluctant to undergo surgical procedures, opening the opportunity for a pharmaceutical approach.

Medical 98

Medical Manufacturing Insurance Side effects 98

Pharmaceutical Technology

FEBRUARY 6, 2023

Leading up to 2023, experts have said a company’s financial wellbeing may depend on its economic position when the market shifted. Bexotegrast is an oral small molecule that inhibits αvβ6/αvβ1. The drug is under development for the treatment of the two rare diseases idiopathic pulmonary fibrosis (IPF) and primary sclerosing cholangitis (PSC).

Marketing 59

Marketing Pharmaceutical FDA Prospecting 59

World of DTC Marketing

APRIL 12, 2022

Many medical professionals, consumer advocates, and academics say that quality and access to care are declining as the industry consolidates and closes smaller practices in poor or rural areas, pushes doctors to increase volumes of patients seen, and encourages more expensive diagnostic tests and the use of less costly equipment.

Healthcare 209

Healthcare Healthcare Insurance Physicians 209

World of DTC Marketing

JULY 28, 2022

Nationwide, prescription drug spending last year is estimated to be $328 billion among all payers, including private insurance, Medicare Part D, and patients’ out-of-pocket expenses. Still, the pharma industry is fighting hard to keep it off the table. Nearly 9 in 10 older adults take prescription medication.

Pharma 256

Pharma Prescription Manufacturing Insurance 256